Delivery Order SPE2DX22D0010-SPE2D825FGC74
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $77,463.67 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, effective through August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The award is non-set-aside and was competitively...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $55,543.32 to AmerisourceBergen Drug Corp on August 4, 2025, under a firm fixed-price contract with an ultimate completion date of August 5, 2025. This non-set-aside award was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $34,011.24 to AmerisourceBergen Drug Corp on June 23, 2025, with completion targeted for June 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was competitively tendered with no set-aside designation...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,609.77 to AmerisourceBergen Drug Corp on July 23, 2025, under a firm fixed price contract. This delivery order, which is part of a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), represents a single transaction fulfilling pharmaceutical and medical supply requirements. The award was...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,379.98 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The award is performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $154,727.82 to AmerisourceBergen Drug Corp on August 18, 2025, with ultimate completion by August 19, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was competitively procured without set-aside designation and is being performed at the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,847.44 to AmerisourceBergen Drug Corp on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,831.66 to AmerisourceBergen Drug Corp on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $275,118.44 to AmerisourceBergen Drug Corp on August 23, 2025, for pharmaceutical and medical supply delivery. This firm fixed price delivery order, which concludes August 25, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,181.69 to AmerisourceBergen Drug Corp on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.9 million through December 2026. The delivery order will be fulfilled from...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FGC74Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $45,142.44 to AmerisourceBergen Drug Corp on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and deliver pharmaceutical products and medical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for military and veteran healthcare systems through its comprehensive product portfolio, which includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract awards demonstrate extensive experience fulfilling delivery orders through open competition, with pricing ranging from small-value transactions to orders exceeding $45,000. As the Defense Logistics Agency prepares to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, AmerisourceBergen remains well-positioned to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.1k | 6/6/25 |